← Every investor
Sivik Global Healthcare LLC Portfolio
$175M across 35 positions as of 2026-09-30, with 46% of it in the ten largest. 4 quarters on file.
How the reported portfolio did
Each 13F's long stock positions, held to the next quarter's end, against the S&P 500. Yearly rates, on closes without dividends.
1 year
+19.8%
+5.3% a year vs the S&P 500
3 years
+14.6%
-6.7% a year vs the S&P 500
5 years
+9.5%
-2.6% a year vs the S&P 500
Quarters ahead
9 of 21
| Quarter | Portfolio | S&P 500 |
|---|---|---|
| Jun 30, 2026 to Sep 30, 2026 | +7.5% | +2.1% |
| Mar 31, 2026 to Jun 30, 2026 | +10.5% | +14.8% |
| Dec 31, 2025 to Mar 31, 2026 | -7.9% | -4.6% |
| Sep 30, 2025 to Dec 31, 2025 | +9.4% | +2.4% |
| Jun 30, 2025 to Sep 30, 2025 | +3.4% | +7.8% |
| Mar 31, 2025 to Jun 30, 2025 | +3.8% | +10.5% |
| Dec 31, 2024 to Mar 31, 2025 | +3.0% | -4.6% |
| Sep 30, 2024 to Dec 31, 2024 | -10.7% | +2.1% |
Largest first
Share is of this manager's reported book. A holding with no symbol is one this site does not track as a company; the filing's own name for it is shown instead.
| Holding | Value | Share | Shares |
|---|---|---|---|
| XBIState Street SPDR S&P Biotech ETF | $28.4M | 16.2% | 180,000 |
| HUMHumana Inc | $6.8M | 3.9% | 17,700 |
| JNJJohnson & Johnson | $6.4M | 3.6% | 24,000 |
| MRKMerck & Co Inc | $5.8M | 3.3% | 40,000 |
| ABBVAbbVie Inc | $5.8M | 3.3% | 22,000 |
| TMOThermo Fisher Scientific Inc | $5.7M | 3.3% | 8,500 |
| CAHCardinal Health Inc | $5.6M | 3.2% | 25,000 |
| MCKMcKesson Corp | $5.5M | 3.2% | 6,500 |
| DHRDanaher Corp | $5.5M | 3.2% | 25,000 |
| UNHUnitedHealth Group Inc | $5.5M | 3.1% | 15,000 |
| VRTXVertex Pharmaceuticals Inc | $5.5M | 3.1% | 10,500 |
| ELVElevance Health Inc | $5.4M | 3.1% | 14,000 |
| ABTAbbott Laboratories | $5.4M | 3.1% | 55,000 |
| CORCencora Inc | $5.4M | 3.1% | 18,000 |
| AAgilent Technologies Inc | $5.2M | 3.0% | 30,000 |
| CNCCentene Corp | $5M | 2.8% | 80,000 |
| LLYEli Lilly and Co | $4.9M | 2.8% | 4,230 |
| EHCEncompass Health Corp | $4.9M | 2.8% | 40,000 |
| RVTYRevvity Inc | $4.6M | 2.6% | 30,000 |
| WATWaters Corp | $4.4M | 2.5% | 10,000 |
| BRKRBruker Corp | $4.2M | 2.4% | 65,000 |
| EWEdwards Lifesciences Corp | $3.9M | 2.2% | 45,000 |
| MEDTRONIC PLC | $3.9M | 2.2% | 45,000 |
| RGENRepligen Corp | $3.8M | 2.2% | 20,000 |
| MTDMettler-toledo International Inc | $3.8M | 2.2% | 2,500 |
| GILDGilead Sciences, Inc | $3.7M | 2.1% | 25,000 |
| CICigna Group | $3.6M | 2.1% | 13,203 |
| BIIBBiogen Inc | $3.4M | 1.9% | 15,000 |
| BIOBio Rad Laboratories Inc | $3M | 1.7% | 8,000 |
| AVTRAvantor Inc | $2.6M | 1.5% | 175,000 |
| BNTXBiontech SE | $2.2M | 1.2% | 22,000 |
| MRNAModerna Inc | $1.9M | 1.1% | 10,000 |
| ARGXargenx SE | $1.9M | 1.1% | 2,000 |
| MDGLMadrigal Pharmaceuticals Inc | $1.3M | 0.7% | 2,500 |
| TWSTTwist Bioscience Corp | $218K | 0.1% | 1,128 |
Quarter ending 2026-09-30.
Follow Sivik Global Healthcare LLC by email
Sivik Global Healthcare LLC's new 13F filings and what changed in them, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.